Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CERK antibody

This anti-CERK antibody is a Rabbit Polyclonal antibody detecting CERK in ELISA and IHC. Suitable for Human and Mouse.
Catalog No. ABIN7236232

Quick Overview for CERK antibody (ABIN7236232)

Target

See all CERK Antibodies
CERK (Ceramide Kinase (CERK))

Reactivity

  • 38
  • 9
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Mouse

Host

  • 34
  • 4
Rabbit

Clonality

  • 37
  • 1
Polyclonal

Conjugate

  • 25
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CERK antibody is un-conjugated

Application

  • 24
  • 13
  • 9
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)
  • Characteristics

    Polyclonal Antibody

    Purification

    Affinity purification

    Immunogen

    Recombinant protein of human CERK

    Isotype

    IgG
  • Application Notes

    IHC 1:25-1:100

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.3 mg/mL

    Buffer

    PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    CERK (Ceramide Kinase (CERK))

    Alternative Name

    CERK

    Background

    CERK converts ceramide to ceramide 1-phosphate (C1P), a sphingolipid metabolite. Both CERK and C1P have been implicated in various cellular processes, including proliferation, apoptosis, phagocytosis, and inflammation. Catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate. Acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide), to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines. Binds phosphoinositides.

    UniProt

    Q8TCT0
You are here:
Chat with us!